Tuesday, May 10, 2022
Partnership and community are central to Capital Factory’s mission, so it’s only fitting that two essential partners help us open the inaugural Health Supernova. As longtime leaders at title sponsors UT Dallas and UT Southwestern Medical Center, Drs. Pancrazio and Nivet will bring their seasoned perspectives to discuss the revolutionary growth driving biotech innovation across the state…and far beyond.
Hear their first-hand experiences in accelerating critical health research and technology development and the focal areas that are changing the face of healthcare and biotech. Walk away with insight on national healthcare and biotech priorities and the driving forces for investment and innovation across the health ecosystem.
Texas as a hotspot for health innovation goes way back. In the 1960s, at the Texas Medical Center, three physicians pioneered heart transplant procedures, the development of left ventricular assist devices (LVAD), and work with artificial hearts. Their efforts changed the face of heart failure. Today, more than 50,000 people have had continuous flow pumps, like the LVAD, implanted.
In this talk, noted surgeon and inventor Dr. Billy Cohn will take us on an illuminating journey of the evolution of human and artificial heart transplants — and offer a look at the future of the artificial heart field. Don’t miss this chance for an expert view into breakthrough medical devices and life-changing innovations such as the design of an artificial heart overnight via a 3-D printer, smart motors and components, and breakthroughs in pumps for both sides of the heart.
The warp speed of technology advancement across healthcare is driving a convergence of innovation and impact on how patients are treated. Hear from three esteemed thought leaders and innovators in biotech+ today who are developing and investing in the technologies to define the future.
Amy Kruse brings insightful perspective on human 2.0 technology and robotics in medical devices that are revolutionizing surgery, prosthetics, imaging, and other critical areas. Claire Aldridge clarifies the post-pandemic opportunities to enable biotech-based therapies that prevent and treat disease. Lauren Tyra covers the waterfront of technologies that enable greater accessibility and equity in healthcare systems. Expect to learn about what matters in healthcare today… and what’s next.
The global prosthetics and orthotics market was valued at ~$6B in 2020 and is expected to grow at a CAGR of 4.2% through 2028. Those figures aren’t surprising. The World Health Organization estimates that 30 million people are in need of prosthetic and orthotic devices right now. That number grows annually, with 185,000 Americans alone suffering the loss of a limb each year. But the prosthetics of tomorrow have the potential to work (and look) far different from those we use today — changing the market as well as the lives of millions.
In this Lightning Talk, Connor Glass will share how his team at Phantom is building a system to help people gain lifelike control of robotic limbs through a unique human-machine interfacing system. This technology, based in reconstructive surgery research at Johns Hopkins, combines small implantable sensors, AI, and software in an effort to allow people to control robotic prostheses and exoskeletons using existing muscles near the location of the amputation.
ALS, or Lou Gehrig’s disease, has a devastating effect on quality of life. What began as an effort to help ALS patients control their extremities with digital interfaces has evolved into a patented electroneurography platform that allows for first-of-its-kind intuitive control of any experience in the IoT universe.
In this Lightning Talk, hear founder Dexter Ang talk about the breakthrough Pison platform. Pison leverages machine learning to interpret the intent of the microvoltage that courses through the human body when our brains communicate with our muscle systems. The applications ahead? Sophisticated prosthetics. Touchless robotics. Sensitive interfaces. Smart(er) home controls. And so much more.
The human brain can generate incredibly complex and beautiful behaviors. These behaviors are driven by neural patterns that have been developing throughout our lifetimes. Yet, following neurological injuries, the neural circuits in our brain change. While some of these changes are helpful and account for functional recovery, maladaptive changes can result in spasticity, chronic pain, tinnitus, phantom limb pain, and other neurological conditions that negatively impact the quality of life.
Robert Rennaker will discuss the use of vagus nerve stimulation to enhance recovery of motor function following spinal cord injury and stroke and to treat post-traumatic stress disorder. His company, X-Nerve, is currently running three clinical trials with a wireless glass encapsulated, ultra-miniature, MRI compatible stimulator that never needs to be replaced. The device is powered by a wearable that can be triggered via Bluetooth, allowing the rapid development of rehabilitation and treatment tools that can take advantage of Targeted Plasticity Therapy. Their goal? To ensure this therapy maximizes recovery, reduces the need for future surgery, and (most importantly) does not prevent the standard of care.
Concurrent sessions can make it tough to choose when there’s so much great content being presented. That’s why David Zakariaie has agreed to give this talk not just once but TWICE! And It’s one you don’t want to miss. ↓
Depression and anxiety rates climbed by more than 25% worldwide in 2020. Yet these numbers were already alarmingly high, with millions suffering from a range of anxiety and depressive disorders along with related struggles in addiction that often accompany these conditions. Post-traumatic Stress Disorder (PTSD) alone affects 7.7 million adults in the United States, approximately 3.5% of the population. Yet the standard of care for mental health diagnosis today is keyed to subjective questionnaires and conventional tests, which take hours to complete and depend solely on patient responses to form a diagnosis. For this and other reasons, millions of those struggling with depression, anxiety, and addiction go undiagnosed and untreated.
To help close this gap in care, Senseye is building a breakthrough diagnostic platform for mental health, starting with PTSD. Using computer vision technology, this tool allows clinicians to gather insights by tracking disruptions in the sympathetic nervous system through the eyes. CEO David Zakariaie will share his vision for the platform, which can be used remotely though widely available smartphone technology to inform a truly objective diagnosis in as little as 10 minutes.
For most nurses, their primary role and motivation is to advocate for patients, care for individuals, and support people through health and illness. Yet 30% of their time is spent on routine tasks, many of which can be addressed through technology. With the number of nurses leaving the workforce each year growing steadily — from around 40,000 in 2010 to nearly 80,000 by 2020 — implementing new technologies now could lower the burden on nurses while improving the overall quality of patient care.
Carisa Raucci from Diligent Robotics is working to be part of that solution. She and her team develop robots that are designed to support and work together with clinical teams so they can focus on caring for patients. In this quick session, Carisa will give you a peek at “Moxi,” a socially intelligent robot that can aid nurses without making humans feel uncomfortable.
InspectIR has created breath analysis technology for portable COVID-19 diagnostic screening applications. InspectIR is the only testing methodology that does not create cross-reactivity, which leads to pre-analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis. InspectIR is the first company to make a commercially available miniature mass spectrometer to analyze breath samples directly.
The brain is a data organ. Everything we touch and everything we experience comes as information to the brain. Similarly, everything we do comes as signals from the brain. The input and output of the brain is information. So could computer chips that connect directly to the brain give sight to people who are blind — or even eliminate mental illness?
Matt Angle and his Paradromics Inc. team are making the brain accessible to direct communication with computers, advanced sensors, or any digital device. As keynote speaker for our Medical Devices track, Matt will discuss their work and offer insights on the role human augmentation and robotics will play in the future of health — a global market that is expected to reach $665B by 2028.
Welcome to the new era of telemedicine, which looks and sounds a lot like a Hollywood movie. Using very real technology being developed and tested by NASA, holoportation combines the words “teleportation” and “hologram” — and it’s a game-changer. NASA tested it for the first time last fall to virtually “send” doctors into space with an ISS crew.
Now meet the team who made it happen. Drs. Schmid and de la Peña will reveal how holoportation leverages haptics for intriguing applications. They’ll talk about what it was like to holoport 16 people to the Space Station, prepare astronauts and engineers in NASA’s extreme undersea training lab, and reduce the side effects of long-term isolation. It’s an intriguing topic you don’t want to miss.
Together with BioLabs, McKesson, and BCBSTX C1 Innovation Lab, we are excited to announce a healthcare investment showcase at Health Supernova 2022!
Five of the hottest healthcare startups in Texas will showcase to an audience of healthcare professionals, investors, and entrepreneurs live at Pegasus Park and online from around the world to be considered for up to $100,000 in investment and a fast track to join Capital Factory.